[ad_1]
Recently, South Korea reported several deaths after flu vaccination. China’s CDC also announced 4 deaths today after flu vaccination. CDC Deputy Director Zhuang Renxiang stated that these 4 deaths were initially ruled out. Regarding influenza vaccination, as of October 26, a total of 76 vaccination-related adverse events had been received, of which 25 were serious adverse events and 13 were prolonged hospitalization or life or death cases.
Zou Zongpei, an epidemic prevention physician with the CDC’s Office of Preventive Medicine, said that of the four deaths after influenza vaccination, three of them were vaccinated with Sanofi, one was vaccinated with Guoguang, and four died among the 62 and 77 years. After CT and cardiac catheterization, the cause of death was determined to be cardiovascular disease, including acute myocardial infarction and subarachnoid hemorrhage. It can be clearly ruled out that the cause of death is related to influenza vaccination.
The Department of Disease Control announced today that it has received 76 notifications of adverse events after vaccination. Compared to the 51 announced on the 24th, an increase of 25 in just 4 days. Zhuang explained that the recent large-scale vaccination outbreak in Korea Adverse events have increased the public’s sensitivity, so it is normal for the number of reported cases to increase. Lin Yongqing, an epidemic prevention doctor at the Office of Preventive Medicine of the Department of Disease Control, also said that domestic adverse events are reported by the public and medical treatment in both directions, in addition to media reports. Notification of suspected adverse events.
Lin Yongqing, for example, received a number of adverse events during H1N1 vaccination in the past, but after the Vaccination Victim Assistance Review Team’s investigation, it was ruled out that up to 90% of cases were related to the vaccine. Therefore, the number of adverse events was used to judge the vaccine. The security is quite inaccurate.
Zhuang Renxiang stressed that South Korean authorities ruled out the association between large-scale deaths and flu vaccines. Also, currently only Singapore has suspended the use of two vaccines, including Sanofi. Therefore, the country will continue to promote vaccination plans against influenza. At the same time, closely monitor the development of adverse events after influenza vaccination.
Zou Zongpei explained that the reason for evaluating the continued promotion of the influenza vaccination plan is to consider that the advantages of vaccination compared to stopping vaccination outweigh the disadvantages, and that the majority of adverse events after vaccination in China they are not serious, and 4 deaths and vaccination were also excluded. Relevant, so the vaccination plan continues. Regarding adverse events of vaccines in South Korea and Taiwan, according to current data, the status is distributed among various brands and lot numbers, so the investigation and trial have nothing to do with vaccination.
(During the middle)
[ad_2]
